NDC11 47781038426
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 47781-0384-26 | 47781-0384 |
| 47781-384-26 | 47781-384 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oseltamivir Phosphate for Oral Suspension | OSELTAMIVIR PHOSPHATE | Alvogen Inc. | 82df3237-636b-7bf9-3ba0-2b476e74bf4c | 2025-02-28 | Warnings, Adverse reactions | 47781-384-26 47781-384 47781038426 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.